• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以分子形状和场相似性为标准来解释基于片段设计铂(IV)抗癌剂的构效关系研究。物理化学性质与细胞毒性的相关性。

The molecular shape and the field similarities as criteria to interpret SAR studies for fragment-based design of platinum(IV) anticancer agents. Correlation of physicochemical properties with cytotoxicity.

作者信息

Lorenzo Julia, Montaña Ángel M

机构信息

Instituto de Biotecnología y Biomedicina Vicent Villar Palasí, Universidad Autónoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.

Unidad de Química Orgánica Industrial y Aplicada, Departamento de Química Orgánica, Universidad de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain.

出版信息

J Mol Graph Model. 2016 Sep;69:39-60. doi: 10.1016/j.jmgm.2016.07.010. Epub 2016 Aug 18.

DOI:10.1016/j.jmgm.2016.07.010
PMID:27567201
Abstract

Molecular shape similarity and field similarity have been used to interpret, in a qualitative way, the structure-activity relationships in a selected series of platinum(IV) complexes with anticancer activity. MM and QM calculations have been used to estimate the electron density, electrostatic potential maps, partial charges, dipolar moments and other parameters to correlate the stereo-electronic properties with the differential biological activity of complexes. Extended Electron Distribution (XED) field similarity has been also evaluated for the free 1,4-diamino carrier ligands, in a fragment-based drug design approach, comparing Connolly solvent excluded surface, hydrophobicity field surface, Van der Waals field surface, nucleophilicity field surface, electrophilicity field surface and the extended electron-distribution maxima field points. A consistency has been found when comparing the stereo-electronic properties of the studied series of platinum(IV) complexes and/or the free ligands evaluated and their in vitro anticancer activity.

摘要

分子形状相似性和场相似性已被用于定性解释一系列具有抗癌活性的铂(IV)配合物的构效关系。分子力学(MM)和量子力学(QM)计算已用于估计电子密度、静电势图、部分电荷、偶极矩和其他参数,以将立体电子性质与配合物的不同生物活性相关联。在基于片段的药物设计方法中,还对游离的1,4-二氨基载体配体评估了扩展电子分布(XED)场相似性,比较了康诺利溶剂排除表面、疏水性场表面、范德华场表面、亲核性场表面、亲电性场表面和扩展电子分布最大场点。在比较所研究的铂(IV)配合物系列和/或评估的游离配体的立体电子性质及其体外抗癌活性时,发现了一致性。

相似文献

1
The molecular shape and the field similarities as criteria to interpret SAR studies for fragment-based design of platinum(IV) anticancer agents. Correlation of physicochemical properties with cytotoxicity.以分子形状和场相似性为标准来解释基于片段设计铂(IV)抗癌剂的构效关系研究。物理化学性质与细胞毒性的相关性。
J Mol Graph Model. 2016 Sep;69:39-60. doi: 10.1016/j.jmgm.2016.07.010. Epub 2016 Aug 18.
2
Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.含有荧光N,N'-双(氨基烷基)-1,4-二氨基蒽醌的双核铂抗癌配合物:两种顺铂耐药细胞系中的细胞处理过程反映了它们耐药谱的差异。
J Biol Inorg Chem. 2005 May;10(3):305-15. doi: 10.1007/s00775-005-0643-7. Epub 2005 Apr 12.
3
Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation.通过不对称酰化来调节铂(IV)抗癌配合物的活性。
J Med Chem. 2012 Sep 13;55(17):7571-82. doi: 10.1021/jm300580y. Epub 2012 Aug 24.
4
Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.人卵巢癌细胞对细胞抑制性双核铂(II)配合物的细胞和生物分子反应。
Apoptosis. 2011 Mar;16(3):288-300. doi: 10.1007/s10495-010-0562-0.
5
Synthesis, biological evaluation and SAR studies of novel bicyclic antitumor platinum(IV) complexes.新型双环抗肿瘤铂(IV)配合物的合成、生物评价及构效关系研究。
Eur J Med Chem. 2014 Aug 18;83:374-88. doi: 10.1016/j.ejmech.2014.06.042. Epub 2014 Jun 21.
6
Synthesis and in vitro pharmacological behavior of platinum(II) complexes containing 1,2-diamino-1-(4-fluorophenyl)-2-alkanol ligands.含 1,2-二氨基-1-(4-氟苯基)-2-烷醇配体的铂(II)配合物的合成及体外药理行为。
J Med Chem. 2013 Oct 24;56(20):7951-64. doi: 10.1021/jm400967z. Epub 2013 Oct 10.
7
Comparison of the electronic properties, and thermodynamic and kinetic parameters of the aquation of selected platinum(II) derivatives with their anticancer IC50 indexes.所选铂(II)衍生物的水合作用的电子性质、热力学和动力学参数与其抗癌IC50指数的比较。
J Mol Model. 2008 Aug;14(8):705-16. doi: 10.1007/s00894-008-0285-0. Epub 2008 Mar 6.
8
Research progress in modern structure of platinum complexes.铂配合物现代结构研究进展。
Eur J Med Chem. 2017 Nov 10;140:349-382. doi: 10.1016/j.ejmech.2017.09.034. Epub 2017 Sep 22.
9
Development and current status of unconventional platinum anticancer complexes.非常规铂类抗癌配合物的发展与现状
Mini Rev Med Chem. 2007 Feb;7(2):203-11. doi: 10.2174/138955707779802615.
10
Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.铂核碱基和核苷配合物模型及其抗肿瘤活性:[PtIV(反式-1R,2R-二氨基环己烷)反式-(乙酸根)2(9-乙基鸟嘌呤)氯]硝酸盐水合物的X射线晶体结构
J Inorg Biochem. 2005 Mar;99(3):795-804. doi: 10.1016/j.jinorgbio.2004.12.015.

引用本文的文献

1
Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.研究卡铂 Pt(IV)前药在人血浆中主要小分子还原剂作用下的还原动力学和机制。
Int J Mol Sci. 2019 Nov 12;20(22):5660. doi: 10.3390/ijms20225660.